JP2015509360A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015509360A5 JP2015509360A5 JP2014556093A JP2014556093A JP2015509360A5 JP 2015509360 A5 JP2015509360 A5 JP 2015509360A5 JP 2014556093 A JP2014556093 A JP 2014556093A JP 2014556093 A JP2014556093 A JP 2014556093A JP 2015509360 A5 JP2015509360 A5 JP 2015509360A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- population
- tissue
- human
- syndecan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004027 cells Anatomy 0.000 claims 29
- 102000003711 Syndecan-2 Human genes 0.000 claims 5
- 108090000054 Syndecan-2 Proteins 0.000 claims 5
- 210000001519 tissues Anatomy 0.000 claims 5
- 201000010099 disease Diseases 0.000 claims 4
- 238000002955 isolation Methods 0.000 claims 4
- 241000700159 Rattus Species 0.000 claims 2
- 210000004962 mammalian cells Anatomy 0.000 claims 2
- 210000000130 stem cell Anatomy 0.000 claims 2
- 210000000577 Adipose Tissue Anatomy 0.000 claims 1
- 210000001185 Bone Marrow Anatomy 0.000 claims 1
- 210000000988 Bone and Bones Anatomy 0.000 claims 1
- 210000000845 Cartilage Anatomy 0.000 claims 1
- 102000008186 Collagen Human genes 0.000 claims 1
- 108010035532 Collagen Proteins 0.000 claims 1
- 210000004696 Endometrium Anatomy 0.000 claims 1
- 210000004700 Fetal Blood Anatomy 0.000 claims 1
- 102000008100 Human Serum Albumin Human genes 0.000 claims 1
- 108091006822 Human Serum Albumin Proteins 0.000 claims 1
- 210000002027 Muscle, Skeletal Anatomy 0.000 claims 1
- 210000002826 Placenta Anatomy 0.000 claims 1
- 210000002536 Stromal Cells Anatomy 0.000 claims 1
- 210000002435 Tendons Anatomy 0.000 claims 1
- 210000003954 Umbilical Cord Anatomy 0.000 claims 1
- 230000002491 angiogenic Effects 0.000 claims 1
- 238000004166 bioassay Methods 0.000 claims 1
- 229960005188 collagen Drugs 0.000 claims 1
- 229920001436 collagen Polymers 0.000 claims 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims 1
- 229920002674 hyaluronan Polymers 0.000 claims 1
- 229960003160 hyaluronic acid Drugs 0.000 claims 1
- 235000015110 jellies Nutrition 0.000 claims 1
- 239000008274 jelly Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000002188 osteogenic Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000002953 phosphate buffered saline Substances 0.000 claims 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- MAKUBRYLFHZREJ-JWBQXVCJSA-M sodium;(2S,3S,4R,5R,6R)-3-[(2S,3R,5S,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylate Chemical compound [Na+].CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@H](O)[C@H]1O MAKUBRYLFHZREJ-JWBQXVCJSA-M 0.000 claims 1
Claims (21)
- 哺乳類間質幹細胞の集団であって、該細胞の30%またはそれ以上がSyndecan−2について陽性である、細胞の集団。
- 前記細胞がマウス、ラット、ウマまたはヒト細胞である、請求項1に記載の細胞の集団。
- 前記細胞がヒト細胞である、請求項2に記載の細胞の集団。
- 前記細胞の40%またはそれ以上がSyndecan−2について陽性である、請求項1から3のいずれかに記載の細胞の集団。
- 前記細胞の50%またはそれ以上がSyndecan−2について陽性である、請求項1から4のいずれかに記載の細胞の集団。
- 前記細胞の75%またはそれ以上がSyndecan−2について陽性である、請求項1から5のいずれかに記載の細胞の集団。
- 間質幹細胞の単離方法であって、Syndecan−2の発現に基づき哺乳類細胞の混合集団から細胞を単離する工程を含む、方法。
- ヒト細胞の単離のための、請求項7に記載の方法。
- マウス、ラットまたはウマ細胞の単離のための、請求項7に記載の方法。
- 前記哺乳類細胞の混合集団が、骨髄、脂肪組織、骨格筋、子宮内膜、胎盤、臍帯血、臍帯、ウォートンジェリーおよび多能性細胞由来細胞から選択される供給源から得られる、請求項7から9のいずれかに記載の方法。
- 骨形成細胞および脈管形成細胞の単離のための、請求項10に記載の方法。
- 間質細胞の単離のための、請求項7から11のいずれかに記載の方法であって、それらの単離された細胞から細胞の集団を誘導する工程をさらに含む、方法。
- 細胞のクローン性集団を得る方法であって、請求項7から11のいずれかに記載の方法に従って単一細胞を単離する工程;および該単一細胞から細胞のクローン性集団を誘導する工程を含む、方法。
- 組織を得る方法であって、請求項7から13のいずれかに従って細胞を得る工程、およびそこから組織を得る工程を含む、方法。
- 前記組織が骨である、請求項14に記載の方法。
- 前記組織が軟骨である、請求項14に記載の方法。
- 前記組織が腱である、請求項14に記載の方法。
- 請求項1から6のいずれかに記載の細胞の使用を含むアッセイ。
- 動物、例えば、ヒトにおいて疾患または障害を治療するための医薬組成物であって、請求項1から6のいずれかに記載の細胞を含む、組成物。
- 生理食塩水またはリン酸緩衝生理食塩水を含み、かつ必要に応じて、ジメチルスルホキシド、ヒト血清アルブミン、ヒアルロン酸およびコラーゲンの1つ以上もまた含む、請求項19に記載の組成物。
- 動物、例えば、ヒトの疾患または障害の治療に使用するための、請求項1から6のいずれかに記載の細胞。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1202319.8A GB201202319D0 (en) | 2012-02-10 | 2012-02-10 | Stromal stem cells |
GB1202319.8 | 2012-02-10 | ||
PCT/EP2013/052692 WO2013117761A1 (en) | 2012-02-10 | 2013-02-11 | Stromal stem cells |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2015509360A JP2015509360A (ja) | 2015-03-30 |
JP2015509360A5 true JP2015509360A5 (ja) | 2015-07-02 |
JP5829765B2 JP5829765B2 (ja) | 2015-12-09 |
Family
ID=45929927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014556093A Active JP5829765B2 (ja) | 2012-02-10 | 2013-02-11 | 間質幹細胞 |
Country Status (22)
Country | Link |
---|---|
US (10) | US11230700B2 (ja) |
EP (4) | EP3492584B1 (ja) |
JP (1) | JP5829765B2 (ja) |
KR (1) | KR102124837B1 (ja) |
CN (1) | CN104302763B (ja) |
AU (1) | AU2013217870B2 (ja) |
BR (1) | BR112014019277A8 (ja) |
CA (1) | CA2863821C (ja) |
CY (1) | CY1116365T1 (ja) |
DK (1) | DK2758523T3 (ja) |
ES (3) | ES2539186T3 (ja) |
GB (1) | GB201202319D0 (ja) |
HR (1) | HRP20150594T1 (ja) |
HU (1) | HUE026480T2 (ja) |
IN (1) | IN2014KN01777A (ja) |
PL (1) | PL2758523T3 (ja) |
PT (1) | PT2758523E (ja) |
RS (1) | RS54073B1 (ja) |
RU (1) | RU2636551C2 (ja) |
SI (1) | SI2758523T1 (ja) |
SM (1) | SMT201500147B (ja) |
WO (1) | WO2013117761A1 (ja) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201202319D0 (en) | 2012-02-10 | 2012-03-28 | Orbsen Therapeutics Ltd | Stromal stem cells |
KR20150143625A (ko) | 2013-04-16 | 2015-12-23 | 오르브센 테라퓨틱스 리미티드 | 신데칸 2의 의학적 용도 |
US20170044497A1 (en) | 2014-02-12 | 2017-02-16 | National University Of Ireland, Galway | Selection and use of stem cells |
KR101690872B1 (ko) | 2014-08-19 | 2016-12-29 | 이화여자대학교 산학협력단 | 편도 유래 중간엽 줄기세포로부터 인슐린 분비 세포의 분화 방법 |
US9716660B2 (en) * | 2014-12-11 | 2017-07-25 | Intel Corporation | Hierarchical enforcement of service flow quotas |
KR101686315B1 (ko) | 2015-01-09 | 2016-12-13 | 이화여자대학교 산학협력단 | 편도 유래 중간엽 줄기세포로부터 슈반 세포의 분화 방법 |
CA3012985A1 (en) | 2015-01-27 | 2016-08-04 | Kardiatonos, Inc. | Biomarkers of vascular disease |
JP6920207B2 (ja) | 2015-03-20 | 2021-08-18 | オルブセン セラピューティクス リミテッド | シンデカン−2のモジュレーターとその使用 |
EP3402489B1 (en) * | 2016-01-15 | 2021-06-09 | Orbsen Therapeutics Limited | Sdc-2 exosome compositions and methods of isolation and use |
CN106177918A (zh) * | 2016-09-30 | 2016-12-07 | 广州赛莱拉干细胞科技股份有限公司 | 一种间充质干细胞注射液及其制备方法和应用 |
WO2018220442A2 (en) * | 2017-05-30 | 2018-12-06 | Orbsen Therapeutics Limited | Stromal stem cell therapeutics and methods of use |
JP7174758B2 (ja) * | 2017-07-14 | 2022-11-17 | オーブセン セラピューティクス リミテッド | Cd39間質幹細胞の単離方法と使用 |
JP2022548778A (ja) | 2019-09-23 | 2022-11-21 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | 線維芽細胞活性化タンパク質(fap)を標的とすることによる腫瘍組織の破壊の方法 |
WO2022179518A1 (en) * | 2021-02-25 | 2022-09-01 | Rosas Ivan O | Anti-fibrotic peptides and uses thereof |
CN116334214A (zh) * | 2023-04-04 | 2023-06-27 | 暨南大学附属第一医院(广州华侨医院) | 一种用于急性心肌梗死和稳定性心绞痛鉴别的生物标志物的ceRNA调控网络及其应用 |
Family Cites Families (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1012403A (en) | 1911-01-23 | 1911-12-19 | Thomas W Mcneill | Smoke-indicator. |
US5486599A (en) | 1989-03-29 | 1996-01-23 | The Board Of Trustees Of The Leland Stanford Junior University | Construction and use of synthetic constructs encoding syndecan |
US5486359A (en) * | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
US5726058A (en) | 1992-12-01 | 1998-03-10 | Jalkanen; Markku | Syndecan stimulation of cellular differentiation |
WO1997034605A1 (en) | 1996-03-21 | 1997-09-25 | Mayo Foundation For Medical Education And Research | Use of nicotine to treat liver disease |
CA2323073C (en) * | 1998-03-13 | 2010-06-22 | Osiris Therapeutics, Inc. | Uses for human non-autologous mesenchymal stem cells |
ATE368731T1 (de) | 1998-05-29 | 2007-08-15 | Osiris Therapeutics Inc | Menschliche cd45+ und/oder fibroblasten+ mesenchymale stammzellen |
JP5090604B2 (ja) | 2000-04-25 | 2012-12-05 | オシリス セラピューティクス,インコーポレイテッド | 動物の関節修復のための医薬組成物調製への間葉幹細胞の使用法 |
US7442390B2 (en) * | 2000-06-05 | 2008-10-28 | University Of South Florida | Method for enhancing engraftment of cells using mesenchymal progenitor cells |
WO2002087609A1 (en) | 2001-05-01 | 2002-11-07 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Identification of a cell surface receptor for papillomaviruses |
WO2003046141A2 (en) | 2001-11-26 | 2003-06-05 | Advanced Cell Technology, Inc. | Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells |
AU2003214857A1 (en) | 2002-01-18 | 2003-09-02 | Regents Of The University Of Minnesota | Syndecans and angiogenesis |
NZ537208A (en) | 2002-06-27 | 2009-02-28 | Adipogen Pharmaceuticals Pty Ltd | Differentiation modulating agents and uses therefor |
CA2547899C (en) * | 2002-12-05 | 2014-04-15 | Case Western Reserve University | Cell-based therapies for ischemia |
JP2007531707A (ja) | 2003-10-15 | 2007-11-08 | ピーディーエル バイオファーマ, インコーポレイテッド | IGの重鎖定常領域の位置250、314および/または428の変異誘発によるFc融合タンパク質血清半減期の改変 |
JP2007530543A (ja) | 2004-03-22 | 2007-11-01 | オシリス セラピューティクス,インコーポレイテッド | 間葉幹細胞及びその使用法 |
BRPI0514387B8 (pt) * | 2004-08-16 | 2021-05-25 | Cellresearch Corp Pte Ltd | método para isolar células-tronco epiteliais ou mesenquimais/progenitoras da membrana amniótica do cordão umbilical, método in vitro para cultivar células-tronco mesenquimais/progenitoras, composição farmacêutica e uso de uma célula-tronco epitelial ou mesenquimal/progenitora |
US20060045872A1 (en) * | 2004-08-25 | 2006-03-02 | Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco | Use of adipose tissue-derived stromal stem cells in treating fistula |
US11268149B2 (en) | 2004-12-08 | 2022-03-08 | Cedars-Sinai Medical Center | Diagnosis and treatment of inflammatory bowel disease |
EP1795588A1 (en) | 2005-12-07 | 2007-06-13 | Cellerix, S.L. | Use of adipose tissue derived mesenchymal stem cells for the treatment of graft versus host disease |
JP5283219B2 (ja) | 2006-04-20 | 2013-09-04 | 学校法人自治医科大学 | ベクター産生型腫瘍標的細胞 |
US20070264239A1 (en) | 2006-05-10 | 2007-11-15 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Isolation of pericytes |
WO2008085229A2 (en) | 2006-11-15 | 2008-07-17 | Arteriocyte Inc. | Cell-based therapies for treating liver disease |
US20080131415A1 (en) | 2006-11-30 | 2008-06-05 | Riddell Stanley R | Adoptive transfer of cd8 + t cell clones derived from central memory cells |
KR100883565B1 (ko) | 2007-02-14 | 2009-02-13 | (주)프로스테믹스 | 지방 줄기세포의 조직 재생 능력을 최적화한 조건 배지를 함유한 조직 재생용 주사제 첨가제 |
KR20080103637A (ko) * | 2007-05-25 | 2008-11-28 | 주식회사 알앤엘바이오 | 지방유래 줄기세포를 함유하는 사지말단부 허혈성 질환의세포치료용 조성물 |
CA2693144A1 (en) | 2007-07-17 | 2009-01-22 | The General Hospital Corporation | Methods to identify and enrich for populations of ovarian cancer stem cells and somatic ovarian stem cells and uses thereof |
CN101835889B (zh) | 2007-10-17 | 2013-07-17 | 特克赛尔公司 | Tr1细胞、间充质干细胞和其用途 |
WO2009100159A2 (en) * | 2008-02-04 | 2009-08-13 | Bipar Sciences, Inc. | Methods of diagnosing and treating parp-mediated diseases |
US20090220588A1 (en) | 2008-02-21 | 2009-09-03 | Massachusetts Institute Of Technology | Simultaneous Delivery of Receptors and/or Co-Receptors for Growth Factor Stability and Activity |
WO2010065239A1 (en) | 2008-12-05 | 2010-06-10 | Wake Forest University Health Sciences | Stem cells from urine and methods for using the same |
KR20100106744A (ko) | 2009-03-24 | 2010-10-04 | 이화여자대학교 산학협력단 | 이동성 피부세포질환 또는 멜라닌 합성관련 질환 예방 또는치료용 조성물 |
WO2010119039A1 (en) | 2009-04-13 | 2010-10-21 | Apceth Gmbh & Co. Kg | Engineered mesenchymal stem cells and method of using same to treat tumors |
KR101301262B1 (ko) | 2009-10-23 | 2013-08-27 | 가톨릭대학교 산학협력단 | TGFβ를 코딩하는 뉴클레오티드 서열이 도입된 간엽줄기세포 및 그의 용도 |
KR101622650B1 (ko) | 2009-12-31 | 2016-06-01 | 엘지디스플레이 주식회사 | 액정 전계 렌즈 및 이를 이용한 입체 표시 장치 |
KR101443478B1 (ko) | 2010-03-10 | 2014-09-22 | 가부시키가이샤 투셀 | 간엽계 줄기 세포를 포함한 세포 제제 및 그의 제조 방법 |
US20130189275A1 (en) | 2010-06-03 | 2013-07-25 | University Of Rochester | Compositions and methods for inhibition of or treatment of dengue virus infection |
WO2011160055A2 (en) | 2010-06-18 | 2011-12-22 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Hair follicle neogenesis |
KR101309910B1 (ko) | 2010-08-06 | 2013-09-17 | 이화여자대학교 산학협력단 | 대장암 진단 및 치료제로서의 신데칸-2 펩티드 단편 |
KR101317507B1 (ko) | 2010-08-30 | 2013-10-15 | 가톨릭대학교 산학협력단 | 레바미피드를 유효성분으로 포함하는 암 또는 면역질환의 예방 또는 치료용 조성물 |
CN103261407B (zh) * | 2010-12-22 | 2016-03-02 | 杜兰教育基金委员会 | 用于识别和培养具有高度增殖潜能的多能间充质干细胞的方法 |
KR20120095022A (ko) | 2011-02-18 | 2012-08-28 | 가톨릭대학교 산학협력단 | 간엽줄기세포 및 면역조절 t 세포를 유효성분으로 포함하는 이식편대숙주질환 예방 또는 치료용 세포치료제 조성물 |
EP2683389B1 (en) | 2011-03-11 | 2017-05-03 | Children's Medical Center Corporation | Methods and compositions relating to mesenchymal stem cell exosomes |
KR101145406B1 (ko) * | 2011-07-06 | 2012-05-15 | (주)지노믹트리 | 장암 진단을 위한 장암 특이적 메틸화 마커 유전자의 메틸화 검출방법 |
GB201202319D0 (en) | 2012-02-10 | 2012-03-28 | Orbsen Therapeutics Ltd | Stromal stem cells |
WO2013134649A1 (en) * | 2012-03-09 | 2013-09-12 | Verastem, Inc. | Biomarkers for cancer stem cells and related methods of use |
WO2013172793A1 (en) | 2012-05-18 | 2013-11-21 | Agency For Science, Technology & Research | Umbilical cord mesenchymal stem cell exosomes |
JP6542197B2 (ja) | 2013-04-12 | 2019-07-10 | エヴォックス・セラピューティクス・リミテッド | 治療的送達小胞 |
KR20150143625A (ko) | 2013-04-16 | 2015-12-23 | 오르브센 테라퓨틱스 리미티드 | 신데칸 2의 의학적 용도 |
US20160220613A1 (en) | 2013-09-16 | 2016-08-04 | Agency For Science, Technology And Research | Method |
PT3091991T (pt) | 2013-12-13 | 2020-02-04 | Swedish Stromabio Ab | Composições imunomodulatórias |
EP3182984B1 (en) | 2014-08-18 | 2019-10-30 | Apceth GmbH & Co. KG | Genetically modified mesenchymal stem cells expressing an immune response-stimulating cytokine to attract and/or activate immune cells |
GB201418562D0 (en) | 2014-10-20 | 2014-12-03 | Univ London Queen Mary | Peptides |
CA2964857A1 (en) | 2014-10-20 | 2016-04-28 | Nestec S.A. | Methods for prediction of anti-tnf alpha drug levels and autoantibody formation |
JP6920207B2 (ja) | 2015-03-20 | 2021-08-18 | オルブセン セラピューティクス リミテッド | シンデカン−2のモジュレーターとその使用 |
EP3402489B1 (en) | 2016-01-15 | 2021-06-09 | Orbsen Therapeutics Limited | Sdc-2 exosome compositions and methods of isolation and use |
CN109071542B (zh) | 2016-02-19 | 2021-07-20 | 凤凰分子设计公司 | 可用作rsk抑制剂的羧酰胺衍生物 |
WO2018220442A2 (en) | 2017-05-30 | 2018-12-06 | Orbsen Therapeutics Limited | Stromal stem cell therapeutics and methods of use |
JP7174758B2 (ja) | 2017-07-14 | 2022-11-17 | オーブセン セラピューティクス リミテッド | Cd39間質幹細胞の単離方法と使用 |
WO2020035741A2 (en) | 2018-07-05 | 2020-02-20 | Novobind Livestock Therapeutics Inc. | Antibodies against disease causing agents of poultry and uses thereof |
US20220288129A1 (en) | 2019-08-23 | 2022-09-15 | Orbsen Therapeutics Limited | Compositions for monocyte and macrophage polarization and methods of use |
-
2012
- 2012-02-10 GB GBGB1202319.8A patent/GB201202319D0/en not_active Ceased
-
2013
- 2013-02-11 JP JP2014556093A patent/JP5829765B2/ja active Active
- 2013-02-11 EP EP18190005.1A patent/EP3492584B1/en active Active
- 2013-02-11 PT PT137072955T patent/PT2758523E/pt unknown
- 2013-02-11 AU AU2013217870A patent/AU2013217870B2/en active Active
- 2013-02-11 DK DK13707295.5T patent/DK2758523T3/da active
- 2013-02-11 BR BR112014019277A patent/BR112014019277A8/pt not_active Application Discontinuation
- 2013-02-11 KR KR1020147025152A patent/KR102124837B1/ko active IP Right Grant
- 2013-02-11 US US14/377,597 patent/US11230700B2/en active Active
- 2013-02-11 ES ES13707295.5T patent/ES2539186T3/es active Active
- 2013-02-11 EP EP13707295.5A patent/EP2758523B1/en active Active
- 2013-02-11 EP EP15158384.6A patent/EP2902482B1/en active Active
- 2013-02-11 EP EP23176834.2A patent/EP4257203A3/en active Pending
- 2013-02-11 SI SI201330036T patent/SI2758523T1/sl unknown
- 2013-02-11 PL PL13707295T patent/PL2758523T3/pl unknown
- 2013-02-11 HU HUE13707295A patent/HUE026480T2/en unknown
- 2013-02-11 RS RS20150392A patent/RS54073B1/en unknown
- 2013-02-11 WO PCT/EP2013/052692 patent/WO2013117761A1/en active Application Filing
- 2013-02-11 RU RU2014136711A patent/RU2636551C2/ru active
- 2013-02-11 ES ES15158384T patent/ES2697780T3/es active Active
- 2013-02-11 CN CN201380019351.0A patent/CN104302763B/zh active Active
- 2013-02-11 CA CA2863821A patent/CA2863821C/en active Active
- 2013-02-11 ES ES18190005T patent/ES2959833T3/es active Active
-
2014
- 2014-08-22 IN IN1777KON2014 patent/IN2014KN01777A/en unknown
-
2015
- 2015-06-03 HR HRP20150594TT patent/HRP20150594T1/hr unknown
- 2015-06-08 CY CY20151100502T patent/CY1116365T1/el unknown
- 2015-06-25 SM SM201500147T patent/SMT201500147B/xx unknown
-
2016
- 2016-04-01 US US15/089,435 patent/US10907131B2/en active Active
-
2018
- 2018-06-14 US US16/009,048 patent/US11142747B2/en active Active
-
2019
- 2019-09-05 US US16/562,206 patent/US10920197B2/en active Active
-
2021
- 2021-09-09 US US17/470,492 patent/US11926848B2/en active Active
- 2021-12-01 US US17/540,067 patent/US11434471B2/en active Active
-
2023
- 2023-06-05 US US18/329,455 patent/US11952589B2/en active Active
- 2023-06-05 US US18/329,435 patent/US11884936B2/en active Active
- 2023-06-05 US US18/329,469 patent/US11952590B2/en active Active
-
2024
- 2024-03-07 US US18/599,002 patent/US20240209319A1/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2015509360A5 (ja) | ||
HRP20150594T1 (hr) | Stromalne matiäśne stanice | |
Schnabel et al. | Therapeutic use of stem cells in horses: which type, how, and when? | |
Toupadakis et al. | Comparison of the osteogenic potential of equine mesenchymal stem cells from bone marrow, adipose tissue, umbilical cord blood, and umbilical cord tissue | |
Taghizadeh et al. | Wharton’s Jelly stem cells: future clinical applications | |
Kulus et al. | Mesenchymal stem/stromal cells derived from human and animal perinatal tissues—origins, characteristics, signaling pathways, and clinical trials | |
Muttini et al. | Ovine amniotic epithelial cells: In vitro characterization and transplantation into equine superficial digital flexor tendon spontaneous defects | |
Arkesteijn et al. | Effect of coculturing canine notochordal, nucleus pulposus and mesenchymal stromal cells for intervertebral disc regeneration | |
Hulme et al. | Cell therapy for cartilage repair | |
Stanco et al. | Multidifferentiation potential of human mesenchymal stem cells from adipose tissue and hamstring tendons for musculoskeletal cell-based therapy | |
US20200291359A1 (en) | Ectodermal mesenchymal stem cells and method for producing same | |
Calloni et al. | Mesenchymal stromal cells from unconventional model organisms | |
US20230295572A1 (en) | Method and composition for inducing chondrogenesis or tenogenesis in mesenchymal stem cells | |
JP2022069524A (ja) | 改良された細胞療法 | |
Ivanovska et al. | Immunophenotypical characterization of canine mesenchymal stem cells from perivisceral and subcutaneous adipose tissue by a species-specific panel of antibodies | |
Arrizabalaga et al. | Properties of porcine adipose-derived stem cells and their applications in preclinical models | |
Wrona et al. | Derivation and characterization of porcine vocal fold extracellular matrix scaffold | |
Leal Reis et al. | Allogenic synovia-derived mesenchymal stem cells for treatment of equine tendinopathies and desmopathies—Proof of concept | |
Chang et al. | The canine epiphyseal-derived mesenchymal stem cells are comparable to bone marrow derived-mesenchymal stem cells | |
Ramzgouyan et al. | Differentiation of human endometrial stem cells into germ cell–Like cell in fibrin scaffold | |
Edaso et al. | Review on applications of stem cells in veterinary therapeutic practices | |
Muramatsu et al. | Intragraft chimerism following composite tissue allograft | |
JP2018501189A (ja) | 骨欠損を治療するための体性幹細胞 | |
Larson et al. | Journal of Cell Science & Therapy | |
Martinello et al. | Comparison in vivo applications between peripheral blood-derived mesenchymal stromal cells (PB-MSCs) and platlet-rich plasma (PRP) in injured tendons of sheep |